Sonora Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Sonora Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5	Closed	-$1K	–	1137
2021 Q2	$1K	Hold	5	–	–	﹤0.01%	974
2021 Q1	$1K	Hold	5	–	–	﹤0.01%	1714
2020 Q4	$1K	Hold	5	–	–	﹤0.01%	1662
2020 Q3	$1K	Hold	5	–	–	﹤0.01%	1746
2020 Q2	$1K	Hold	5	–	–	﹤0.01%	1721
2020 Q1	$0	Sell	5 -15	-75%	-$1.47K	﹤0.01%	1776
2019 Q4	$2K	Buy	+20	New	+$2.14K	﹤0.01%	1598
2019 Q3	–	Sell	-20	Closed	-$3K	–	1841
2019 Q2	$3K	Hold	20	–	–	﹤0.01%	1533
2019 Q1	$3K	Hold	20	–	–	﹤0.01%	1358
2018 Q4	$2K	Buy	20 +15	+300%	+$1.77K	﹤0.01%	1159
2018 Q3	$1K	Hold	5	–	–	﹤0.01%	1173
2018 Q2	$1K	Hold	5	–	–	﹤0.01%	1135
2018 Q1	$557	Hold	5	–	–	﹤0.01%	1144
2017 Q4	$598	Buy	+5	New	+$609	﹤0.01%	1154
2015 Q4	–	Sell	-15	Closed	-$3K	–	1214
2015 Q3	$3K	Buy	+15	New	+$2.74K	﹤0.01%	938

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Sonora Investment Management's ALXN Position: Q3 2021 in Review

Sonora Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 5 shares — an estimated $1K sold.

Sonora Investment Management first reported a position in ALXN in Q3 2015 and held it in 15 quarters. The position peaked at $3K in Q2 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Sonora Investment Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Sonora Investment Management sold 5 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1K.
Sonora Investment Management first reported a position in Alexion Pharmaceuticals in Q3 2015 and held it in 15 quarters.
Sonora Investment Management's Alexion Pharmaceuticals position peaked at $3K in Q2 2019.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.